Center-Authored Papers

Filters: Author is Chlebowski, Rowan T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Adams SV, Quraishi SM, Shafer MM, Passarelli MN, Freney EP, Chlebowski RT, Luo J, Meliker JR, Mu L, Neuhouser ML et al..  2014.  Dietary Cadmium Exposure and Risk of Breast, Endometrial, and Ovarian Cancer in the Women's Health Initiative.. Environmental health perspectives. 122(6):594-600. Abstract
Anderson GL, Chlebowski RT, Aragaki AK, Kuller LH, Manson JE, Gass M, Bluhm E, Connelly S, Hubbell AF, Lane D et al..  2012.  Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.. The lancet oncology. 13(5):476-486. Abstract
B
Bertone-Johnson ER, McTiernan A, Thomson CA, Wactawski-Wende J, Aragaki AK, Rohan TE, Vitolins MZ, Tamimi RM, Johnson KC, Lane D et al..  2012.  Vitamin D and Calcium Supplementation and One-Year Change in Mammographic Density in the Women's Health Initiative Calcium and Vitamin D Trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(3):462-73. Abstract
Bertone-Johnson ER, Chlebowski RT, Manson JE, Wactawski-Wende J, Aragaki AK, Tamimi RM, Rexrode KM, Thomson CA, Rohan TE, Peck JD et al..  2010.  Dietary vitamin D and calcium intake and mammographic density in postmenopausal women.. Menopause (New York, N.Y.). 17(6):1152-60. Abstract
Bodelon C, Anderson GL, Rossing MA, Chlebowski RT, Ochs-Balcom HM, Vaughan TL.  2011.  Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women.. Cancer prevention research (Philadelphia, Pa.). 4(6):840-50. Abstract
Brasky TM, Krok-Schoen JL, Liu J, Chlebowski RT, Freudenheim JL, Lavasani S, Margolis KL, Qi L, Reding KW, Shields PG et al..  2017.  Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(8):1345-1348. Abstract
Brunner RL, Wactawski-Wende J, Caan BJ, Cochrane BB, Chlebowski RT, Gass MLS, Jacobs ET, LaCroix AZ, Lane D, Larson J et al..  2011.  The Effect of Calcium plus Vitamin D on Risk for Invasive Cancer: Results of the Women's Health Initiative (WHI) Calcium Plus Vitamin D Randomized Clinical Trial.. Nutrition and cancer. 63(6):827-41. Abstract
Byrne C, Ursin G, Martin CF, Peck JD, Cole EB, Zeng D, Kim E, Yaffe MD, Boyd NF, Heiss G et al..  2017.  Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.. Journal of the National Cancer Institute. 109(9) Abstract
C
Catsburg C, Gunter MJ, Tinker L, Chlebowski RT, Pollak M, Strickler HD, Cote ML, Page DL, Rohan TE.  2015.  Serum IGFBP-2 and Risk of Atypical Hyperplasia of the Breast.. Journal of cancer epidemiology. 2015:203284. Abstract
Cauley JA, Chlebowski RT, Wactawski-Wende J, Robbins JA, Rodabough RJ, Chen Z, Johnson KC, O'Sullivan MJ, Jackson RD, Manson JE.  2013.  Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.. Journal of women's health (2002). 22(11):915-29. Abstract
Cespedes Feliciano EM, Prentice RL, Aragaki AK, Neuhouser ML, Banack HR, Kroenke CH, Ho GYF, Zaslavsky O, Strickler HD, Cheng T-YD et al..  2017.  Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health Initiative.. International journal of cancer. Abstract
Cheng T-YD, LaCroix AZ, Beresford SAA, Goodman GE, Thornquist MD, Zheng Y, Chlebowski RT, Ho GYF, Neuhouser ML.  2013.  Vitamin D intake and lung cancer risk in the Women's Health Initiative.. The American journal of clinical nutrition. 98(4):1002-11. Abstract
Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE et al..  2010.  Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.. JAMA : the journal of the American Medical Association. 304(15):1684-92. Abstract
Chlebowski RT, Rohan TE, Manson JE, Aragaki AK, Kaunitz A, Stefanick ML, Simon MS, Johnson KC, Wactawski-Wende J, O'Sullivan MJ et al..  2015.  Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.. JAMA oncology. 1(3):296-305. Abstract
Chlebowski RT, Anderson GL.  2012.  Changing concepts: Menopausal hormone therapy and breast cancer.. Journal of the National Cancer Institute. 104(7):517-27. Abstract
Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S et al..  2008.  Calcium plus vitamin D supplementation and the risk of breast cancer.. Journal of the National Cancer Institute. 100(22):1581-91. Abstract
Chlebowski RT, Pettinger M, Johnson KC, Wallace R, Womack C, Mossavar-Rahmani Y, Stefanick M, Wactawski-Wende J, Carbone L, Lu B et al..  2013.  Calcium Plus Vitamin D Supplementation and Joint Symptoms in Postmenopausal Women in the Women's Health Initiative Randomized Trial.. Journal of the Academy of Nutrition and Dietetics. 113(10):1302-10. Abstract
Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE et al..  2009.  Breast cancer after use of estrogen plus progestin in postmenopausal women.. The New England journal of medicine. 360(6):573-87. Abstract
Chlebowski RT, Nikolaenko L, Anderson G.  2013.  Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings.. The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists. 39(3):226-8.
Chlebowski RT, Anderson GL.  2014.  Menopausal hormone therapy and cancer: Changing clinical observations of target site specificity.. Steroids. Abstract
Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C et al..  2013.  Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study.. Journal of the National Cancer Institute. 105(8):526-35. Abstract
Chlebowski RT, Wakelee H, Pettinger M, Rohan T, Liu J, Simon M, Tindle H, Messina C, Johnson K, Schwartz A et al..  2015.  Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial.. Clinical lung cancer. Abstract
Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, Gass M, Rodabough RJ, Johnson KC, Wactawski-Wende J, Kotchen JM et al..  2010.  Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.. Journal of the National Cancer Institute. 102(18):1413-21. Abstract
Chlebowski RT, Aragaki AK, Anderson GL.  2015.  Menopausal Hormone Therapy Influence on Breast Cancer Outcomes in the Women's Health Initiative.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(7):917-24. Abstract
Chlebowski RT, Anderson GL.  2015.  Menopausal hormone therapy and breast cancer mortality: clinical implications.. Therapeutic advances in drug safety. 6(2):45-56. Abstract